VASH1 anticorps (AA 281-365)
-
- Antigène Voir toutes VASH1 Anticorps
- VASH1 (Vasohibin 1 (VASH1))
-
Épitope
- AA 281-365
-
Reactivité
- Humain, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp VASH1 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Humain, Rat
- Homologie
- Mouse,Dog,Cow,Pig,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human VASH1
- Isotype
- IgG
- Top Product
- Discover our top product VASH1 Anticorps primaire
-
-
- Indications d'application
- WB 1:300-5000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- VASH1 (Vasohibin 1 (VASH1))
- Autre désignation
- VASH1 (VASH1 Produits)
- Synonymes
- anticorps KIAA1036, anticorps AI834978, anticorps D930046M13Rik, anticorps G630009D10Rik, anticorps RGD1564082, anticorps vasohibin 1, anticorps VASH1, anticorps vash1, anticorps Vash1
- Sujet
-
Synonyms: KIAA1036, Vasohibin-1, VASH1, VASH
Background: Angiogenesis inhibitor. Inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis. This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts. Does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis. Acts in an autocrine manner. Inhibits artery neointimal formation and macrophage infiltration. Exhibits heparin-binding activity.
- ID gène
- 22846
- UniProt
- Q7L8A9
-